Evidence map›Paper›PMID 37376447›Full record

ArticleVaccines2023

Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study.

Esperança Lourenço Guimarães, Assucênio Chissaque, Clint Pecenka, Frédéric Debellut, Anne Schuind, Basília Vaz, Arlindo Banze, Ricardina Rangeiro, Arlete Mariano, Cesaltina Lorenzoni and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Accelerating HPV vaccination in Africa for health equity.Global health research and policy · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 4 countries.

Esperança Lourenço GuimarãesInstituto Nacional de Saúde, Marracuene District, EN1, Bairro da Vila-Parcela N° 3943, Maputo 1120, Mozambique.ORCID 0000-0003-3402-7597
Assucênio ChissaqueInstituto Nacional de Saúde, Marracuene District, EN1, Bairro da Vila-Parcela N° 3943, Maputo 1120, Mozambique.ORCID 0000-0002-9470-6068
Clint PecenkaCenter for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.
Frédéric DebellutCenter for Vaccine Innovation and Access, PATH, 1202 Geneva, Switzerland.ORCID 0000-0002-3027-2838
Anne SchuindCenter for Vaccine Innovation and Access, PATH, Seattle, WA 98121, USA.
Basília VazMinistry of Health, Maputo 1008, Mozambique.
Arlindo BanzeMinistry of Health, Maputo 1008, Mozambique.
Ricardina RangeiroNational Cancer Control Program, Hospital Central de Maputo, Maputo 1101, Mozambique.
Arlete MarianoNational Cancer Control Program, Hospital Central de Maputo, Maputo 1101, Mozambique.
Cesaltina LorenzoniNational Cancer Control Program, Hospital Central de Maputo, Maputo 1101, Mozambique.
Carla CarrilhoDepartment of Pathology, Universidade Eduardo Mondlane, Maputo 3453, Mozambique.ORCID 0000-0003-0208-7309
Maria do Rosário Oliveira MartinsGlobal Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa, Junqueira Street 100, 1349-008 Lisbon, Portugal.ORCID 0000-0002-7941-0285
Nilsa de DeusInstituto Nacional de Saúde, Marracuene District, EN1, Bairro da Vila-Parcela N° 3943, Maputo 1120, Mozambique.
Andrew ClarkDepartment of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.
Instituto Nacional de Saúde · MZMaputo Central Hospital · MZMinistry of Health · MZProgram for Appropriate Technology in Health · USEduardo Mondlane University · MZLondon School of Hygiene & Tropical Medicine · GBUniversidade Nova de Lisboa · PT

Funding

Program for Appropriate Technology in Health GAT.2111-01707508-SUB
6 · The paper itself

Abstract

Mozambique has one of the highest rates of cervical cancer in the world. Human papillomavirus (HPV) vaccination was introduced in 2021. This study evaluated the health and economic impact of the current HPV vaccine (GARDASIL

Indexed as

cervical cancercost-effectivenessmodellingMozambiquepapillomavirusUNIVACvaccination

Identifiers

PMID37376447
PMCPMC10304296
OpenAlexW4379232304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.